Associated Papers
Mutations in CREBBP and EP300 HAT and Bromo Domains Drive Hypermutation and Predict Survival in GI Cancers Treated with Immunotherapy.
Gusakova M et al.
Biomedicines, 2025
41301688 (PubMed )
Supplement: biomedicines-13-02592-s001.zip › Supplementary_Table_S7.xlsx › ____1
Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer.
Eklund EA et al.
Journal of Experimental & Clinical Cancer Research : Cr, 2025
40011914 (PubMed )
Supplement: 13046_2025_3342_MOESM6_ESM.xlsx › VUS_
Select a paper to view details